US 11,789,029 B2
Temporal traumatic brain injury biomarkers and methods of use thereof
Briana Martinez, Tempe, AZ (US); Sarah Stabenfeldt, Tempe, AZ (US); Chris Diehnelt, Chandler, AZ (US); Nicholas Stephanopoulos, Scottsdale, AZ (US); Crystal Willingham, Tempe, AZ (US); Amanda Witten, Phoenix, AZ (US); and Kendall Lundgreen, Gilbert, AZ (US)
Assigned to Arizona Board of Regents on Behalf of Arizona State University, Scottsdale, AZ (US)
Appl. No. 17/620,088
Filed by ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY, Scottsdale, AZ (US)
PCT Filed Jun. 19, 2020, PCT No. PCT/US2020/038795
§ 371(c)(1), (2) Date Dec. 16, 2021,
PCT Pub. No. WO2020/257690, PCT Pub. Date Dec. 24, 2020.
Claims priority of provisional application 62/968,148, filed on Jan. 30, 2020.
Claims priority of provisional application 62/865,009, filed on Jun. 21, 2019.
Prior Publication US 2022/0268788 A1, Aug. 25, 2022
Int. Cl. C07K 7/06 (2006.01); C07K 7/08 (2006.01); G01N 33/68 (2006.01)
CPC G01N 33/6896 (2013.01) [C07K 7/06 (2013.01); C07K 7/08 (2013.01); G01N 2800/28 (2013.01)] 20 Claims
 
1. A peptide having less than 30 amino acid residues comprising a recognition sequence selected from the group consisting of: TAERDARTFQY (SEQ ID NO. 1), SLYGSSRHTAPISF (SEQ ID NO. 2), TDLAVAHPVRY (SEQ ID NO. 3), AAPSWNNHVSY (SEQ ID NO. 4), RLVRESSQEHTLSS (SEQ ID NO. 5), TDCQETPYELKS (SEQ ID NO. 6), TGHEGENEMAS (SEQ ID NO. 7), GPLDGKEEELRF (SEQ ID NO. 8), or GGDTFRDASQSMHF (SEQ ID NO. 9).